AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 129 filers reported holding AUDENTES THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.30 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $37,221,000 | -52.5% | 622,011 | -77.7% | 0.01% | -55.6% |
| Q3 2019 | $78,360,000 | -29.5% | 2,789,574 | -5.0% | 0.02% | -28.0% |
| Q2 2019 | $111,117,000 | -15.0% | 2,934,933 | -12.4% | 0.02% | -16.7% |
| Q1 2019 | $130,696,000 | +81.3% | 3,349,471 | -0.9% | 0.03% | +66.7% |
| Q4 2018 | $72,085,000 | -44.9% | 3,381,070 | +2.4% | 0.02% | -35.7% |
| Q3 2018 | $130,781,000 | +2.4% | 3,303,402 | -1.2% | 0.03% | 0.0% |
| Q2 2018 | $127,765,000 | +2.2% | 3,343,727 | -19.6% | 0.03% | 0.0% |
| Q1 2018 | $125,007,000 | – | 4,159,968 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 1,204,615 | $37,644,219,000 | 39.61% |
| Casdin Capital, LLC | 400,000 | $12,500,000 | 3.04% |
| Opaleye Management Inc. | 210,000 | $6,652,000 | 2.13% |
| Orbimed Advisors | 4,129,638 | $129,051,000 | 1.63% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,190,516 | $37,204,000 | 1.46% |
| Redmile Group, LLC | 929,326 | $29,041,000 | 1.26% |
| Cormorant Asset Management, LP | 337,876 | $10,559,000 | 1.10% |
| Perceptive Advisors | 781,309 | $24,416,000 | 0.81% |
| Rock Springs Capital Management LP | 525,000 | $16,406,000 | 0.74% |
| Virtus ETF Advisers LLC | 11,898 | $372,000 | 0.47% |